Cargando…
Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting immune homeostasis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is defined as an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 and celiac disease (CD) is one of the autoimmune multiorgan diseases, which can be accompanied by an increased risk of viral infections. CD patients,...
Autores principales: | Asri, Nastaran, Nazemalhosseini Mojarad, Ehsan, Mirjalali, Hamed, Mohebbi, Seyed Reza, Baghaei, Kaveh, Rostami-Nejad, Mohammad, Yadegar, Abbas, Rezaei-Tavirani, Mostafa, Asadzadeh Aghdaei, Hamid, Rostami, Kamran, Masotti, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665626/ https://www.ncbi.nlm.nih.gov/pubmed/34895167 http://dx.doi.org/10.1186/s12876-021-02056-1 |
Ejemplares similares
-
Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients
por: Mohebbi, Seyed Reza, et al.
Publicado: (2020) -
The modulation of macrophage subsets in celiac disease pathogenesis
por: Molaaghaee‐Rouzbahani, Sara, et al.
Publicado: (2022) -
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects
por: Abdolahi, Shahrokh, et al.
Publicado: (2022) -
Novel Therapeutic Strategies for Celiac Disease
por: Asri, Nastaran, et al.
Publicado: (2020) -
The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2
por: Mirjalali, Hamed, et al.
Publicado: (2020)